Efficacy and Safety Study of BCX7353 as an Oral Treatment for the Prevention of Attacks in HAE

NCT03485911 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

121

Enrollment

INDUSTRY

Sponsor class

Conditions

Hereditary Angioedema
HAE

Interventions

DRUG: BCX7353 capsules
DRUG: Placebo oral capsule

Sponsor

BioCryst Pharmaceuticals